ERAS-801
UNII B68F5P9PB7

Substance Identification & Data

This profile provides standardized clinical and technical data for Eras-801, uniquely identified by the FDA Unique Ingredient Identifier (UNII) B68F5P9PB7.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2490431-16-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
B68F5P9PB7
CAS Registry Number
2490431-16-6
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ERAS-801
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C22H23BrFN5O2
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
PHQOQKGDQRKQNK-AWEZNQCLSA-N
Line notation for describing the chemical structure and connectivity of atoms.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
PubChem CID
Unique identification number in the NCBI database of chemical substances.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
n1cnc(c2c1cc3c(c2)O[C@@H](CN4CCN(CC4)C)CO3)Nc5c(F)c(ccc5)Br

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Eras-801. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Systematic Nomenclature

(1,4)DIOXINO(2,3-G)QUINAZOLIN-4-AMINE, N-(3-BROMO-2-FLUOROPHENYL)-7,8-DIHYDRO-7-((4-METHYL-1-PIPERAZINYL)METHYL)-, (7S)-
(7S)-N-(3-BROMO-2-FLUOROPHENYL)-7-((4-METHYLPIPERAZIN-1-YL)METHYL)-7H,8H-(1,4)DIOXINO(2,3-G)QUINAZOLIN-4-AMINE

Technical Codes

ERAS-801